BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Corcoran SE, Halai R, Cooper MA. Pharmacological Inhibition of the Nod-Like Receptor Family Pyrin Domain Containing 3 Inflammasome with MCC950. Pharmacol Rev 2021;73:968-1000. [PMID: 34117094 DOI: 10.1124/pharmrev.120.000171] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Song Y, Yuan M, Xu Y, Xu H. Tackling Inflammatory Bowel Diseases: Targeting Proinflammatory Cytokines and Lymphocyte Homing. Pharmaceuticals 2022;15:1080. [DOI: 10.3390/ph15091080] [Reference Citation Analysis]
2 Xu Q, Sun W, Zhang J, Mei Y, Bao J, Hou S, Zhou X, Mao L. Inflammasome-targeting natural compounds in inflammatory bowel disease: Mechanisms and therapeutic potential. Front Immunol 2022;13:963291. [DOI: 10.3389/fimmu.2022.963291] [Reference Citation Analysis]
3 Wong WT, Wu CH, Li LH, Hung DY, Chiu HW, Hsu HT, Ho CL, Chernikov OV, Cheng SM, Yang SP, Chung CH, Hua KF, Wang CF. The leaves of the seasoning plant Litsea cubeba inhibit the NLRP3 inflammasome and ameliorate dextran sulfate sodium-induced colitis in mice. Front Nutr 2022;9:871325. [PMID: 35967819 DOI: 10.3389/fnut.2022.871325] [Reference Citation Analysis]
4 Huot-marchand S, Nascimento M, Culerier E, Bourenane M, Savigny F, Panek C, Serdjebi C, Le Bert M, Quesniaux VFJ, Ryffel B, Broz P, Riteau N, Gombault A, Couillin I. Cigarette smoke-induced gasdermin D activation in bronchoalveolar macrophages and bronchial epithelial cells dependently on NLRP3. Front Immunol 2022;13:918507. [DOI: 10.3389/fimmu.2022.918507] [Reference Citation Analysis]
5 Barczuk J, Siwecka N, Lusa W, Rozpędek-kamińska W, Kucharska E, Majsterek I. Targeting NLRP3-Mediated Neuroinflammation in Alzheimer’s Disease Treatment. IJMS 2022;23:8979. [DOI: 10.3390/ijms23168979] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 Chen M, Rong R, Xia X. Spotlight on pyroptosis: role in pathogenesis and therapeutic potential of ocular diseases. J Neuroinflammation 2022;19:183. [PMID: 35836195 DOI: 10.1186/s12974-022-02547-2] [Reference Citation Analysis]
7 Guo L, Zhang Y, Liu H, Cheng Q, Yang S, Yang D. All-trans retinoic acid inhibits the osteogenesis of periodontal ligament stem cells by promoting IL-1β production via NF-κB signaling. International Immunopharmacology 2022;108:108757. [DOI: 10.1016/j.intimp.2022.108757] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Zha Z, Chen Q, Xiao D, Pan C, Xu W, Shen L, Shen J, Chen W. Mussel-Inspired Microgel Encapsulated NLRP3 Inhibitor as a Synergistic Strategy Against Dry Eye. Front Bioeng Biotechnol 2022;10:913648. [DOI: 10.3389/fbioe.2022.913648] [Reference Citation Analysis]
9 González-candia A, Candia AA, Paz A, Mobarec F, Urbina-varela R, Campo AD, Herrera EA, Castillo RL. Cardioprotective Antioxidant and Anti-Inflammatory Mechanisms Induced by Intermittent Hypobaric Hypoxia. Antioxidants 2022;11:1043. [DOI: 10.3390/antiox11061043] [Reference Citation Analysis]
10 Liu Y, Xu X, Lei W, Hou Y, Zhang Y, Tang R, Yang Z, Tian Y, Zhu Y, Wang C, Deng C, Zhang S, Yang Y. The NLRP3 inflammasome in fibrosis and aging: The known unknowns. Ageing Res Rev 2022;79:101638. [PMID: 35525426 DOI: 10.1016/j.arr.2022.101638] [Reference Citation Analysis]
11 Yuan JY, Fu Y, Feng ZH, Sang F, Shao MY, Li LL. Potential Mechanisms and Effects of Chinese Medicines in Treatment of Diabetic Atherosclerosis by Modulating NLRP3 Inflammasome: A Narrative Review. Chin J Integr Med 2022. [PMID: 35507299 DOI: 10.1007/s11655-022-3513-4] [Reference Citation Analysis]
12 Coll RC, Schroder K, Pelegrín P. NLRP3 and pyroptosis blockers for treating inflammatory diseases. Trends Pharmacol Sci 2022:S0165-6147(22)00083-9. [PMID: 35513901 DOI: 10.1016/j.tips.2022.04.003] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
13 Oronsky B, Caroen S, Abrouk N, Reid TR. RRx-001 and the “Right stuff”: Protection and treatment in outer space. Life Sciences in Space Research 2022. [DOI: 10.1016/j.lssr.2022.05.001] [Reference Citation Analysis]
14 Bakhshi S, Shamsi S. MCC950 in the treatment of NLRP3-mediated inflammatory diseases: Latest evidence and therapeutic outcomes. International Immunopharmacology 2022;106:108595. [DOI: 10.1016/j.intimp.2022.108595] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
15 Liu D, Lv F, Min S, Yang Y, Chen L. Inhibition of NLRP3 inflammasome-mediated neuroinflammation alleviates electroconvulsive shock-induced memory impairment via regulation of hippocampal synaptic plasticity in depressive rats. Behav Brain Res 2022;:113879. [PMID: 35390431 DOI: 10.1016/j.bbr.2022.113879] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Murakami M, Osuka S, Muraoka A, Hayashi S, Bayasula, Kasahara Y, Sonehara R, Hariyama Y, Shinjo K, Tanaka H, Miyake N, Yoshita S, Nakanishi N, Nakamura T, Goto M, Kajiyama H. Effectiveness of NLRP3 Inhibitor as a Non-Hormonal Treatment for ovarian endometriosis. Reprod Biol Endocrinol 2022;20:58. [PMID: 35351143 DOI: 10.1186/s12958-022-00924-3] [Reference Citation Analysis]
17 González-moro A, Valencia I, Shamoon L, Sánchez-ferrer CF, Peiró C, de la Cuesta F. NLRP3 Inflammasome in Vascular Disease: A Recurrent Villain to Combat Pharmacologically. Antioxidants 2022;11:269. [DOI: 10.3390/antiox11020269] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Cliff CL, Williams BM, Chadjichristos CE, Mouritzen U, Squires PE, Hills CE. Connexin 43: A Target for the Treatment of Inflammation in Secondary Complications of the Kidney and Eye in Diabetes. Int J Mol Sci 2022;23:600. [PMID: 35054783 DOI: 10.3390/ijms23020600] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
19 Bonam SR, Tranchant C, Muller S. Autophagy-Lysosomal Pathway as Potential Therapeutic Target in Parkinson's Disease. Cells 2021;10:3547. [PMID: 34944054 DOI: 10.3390/cells10123547] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
20 Yan W, Shen Y, Huang J, Lu L, Zhang Q. MCC950 Ameliorates Acute Liver Injury Through Modulating Macrophage Polarization and Myeloid-Derived Suppressor Cells Function. Front Med (Lausanne) 2021;8:752223. [PMID: 34869447 DOI: 10.3389/fmed.2021.752223] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
21 Zhang X, Hu L, Xu S, Ye C, Chen A. Erianin: A Direct NLRP3 Inhibitor With Remarkable Anti-Inflammatory Activity. Front Immunol 2021;12:739953. [PMID: 34745110 DOI: 10.3389/fimmu.2021.739953] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
22 Wei Z, Zhan X, Ding K, Xu G, Shi W, Ren L, Fang Z, Liu T, Hou X, Zhao J, Li H, Li J, Li Z, Li Q, Lin L, Yang Y, Xiao X, Bai Z, Cao J. Dihydrotanshinone I Specifically Inhibits NLRP3 Inflammasome Activation and Protects Against Septic Shock In Vivo. Front Pharmacol 2021;12:750815. [PMID: 34721038 DOI: 10.3389/fphar.2021.750815] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
23 Buckley CD, Chernajovsky L, Chernajovsky Y, Modis LK, O'Neill LA, Brown D, Connor R, Coutts D, Waterman EA, Tak PP. Immune-mediated inflammation across disease boundaries: breaking down research silos. Nat Immunol 2021;22:1344-8. [PMID: 34675389 DOI: 10.1038/s41590-021-01044-7] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
24 Ge K, Wang Y, Li P, Li M, Zhang W, Dan H, Hu X, Zhou J, Yang Q, Wang J, Song Z. Down-expression of the NLRP3 inflammasome delays the progression of diabetic retinopathy. Microvasc Res 2022;139:104265. [PMID: 34662588 DOI: 10.1016/j.mvr.2021.104265] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
25 Lei I, Tang PC. Commentary: The next chapter in donor heart preservation: Modulation of preservation biology by targeted molecular therapies. JTCVS Tech 2021;9:95-6. [PMID: 34647072 DOI: 10.1016/j.xjtc.2021.06.037] [Reference Citation Analysis]
26 Aguilera M, Rossini V, Hickey A, Simnica D, Grady F, Felice VD, Moloney A, Pawley L, Fanning A, McCarthy L, O'Mahony SM, Cryan JF, Nally K, Shanahan F, Melgar S. Inflammasome Signaling Regulates the Microbial-Neuroimmune Axis and Visceral Pain in Mice. Int J Mol Sci 2021;22:8336. [PMID: 34361102 DOI: 10.3390/ijms22158336] [Cited by in F6Publishing: 1] [Reference Citation Analysis]